FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study - Concepedia

Concepedia

Publication | Closed Access

FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study

57

Citations

36

References

2013

Year

Thomas Brodowicz, Tudor–Eliade Ciuleanu, Davorin Radosavljević, Einat Shacham‐Shmueli, D. Vrbanec, Signe Plāte, Zrinka Mršić-Krmpotić, Magdolna Dank, Gunta Purkalne, Diethelm Messinger,

Annals of Oncology

References

	Year	Citations

Page 1